Alzheimer's disease

Studying vegetables and fruits for the removal of disease-causing cell plaques, a Turkish scientist has managed to remove plaques that lead to ALS disease with celery extract.

The US Food and Drug Administration on Jan. 6 approved a highly anticipated new drug designed to slow cognitive decline in patients in mild and early stages of Alzheimer's disease.

The metal may play a role in forming the neuron-killing plaques associated with Alzheimer’s

The number of people living with dementia will increase by 2030 from the current 55 million to 78 million, and by 2050 - to 139 million. This is the forecast of the World Health Organization (WHO), published in Geneva.

A person's strength may vary from season to season, but the peak of cognitive activity is in the fall. The results of a study by scientists from the United States, Canada, France and Israel show this. They have conducted cognitive and concentration tests among 3,500 respondents over 60, according to Coffee Pause.

With addition of 4.6 million new cases every year, the number of people affected by Alzheimer's disease or dementia is expected to double in next 20 years.

Scientists researching dementia and Alzheimer's disease are shifting their focus to a series of proteins that build up in the brain like debris and have a toxic impact on cells, a development that may help improve diagnoses and therapy.

Apple Inc. is partnering with Eli Lilly in a study to determine if data from the iPhone and Apple Watches can help detect early signs of dementia, CNBC business reported, quoted by BNR.

The two companies are working with Evidation health tech startup to find ways to detect early signs of dementia with the help of Apple's popular tech gadgets.

The number of people suffering from Alzheimer's disease in Greece is increasing rapidly and is expected to triple over the next 30 years, experts say.

An estimated 160,000 people are currently diagnosed with Alzheimer's in Greece, a number expected to rise to 340,000 in 2030 and 560,000 in 2050.